BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23931498)

  • 1. Impact of adding prophylactic probiotics to a bundle of standard preventative measures for Clostridium difficile infections: enhanced and sustained decrease in the incidence and severity of infection at a community hospital.
    Maziade PJ; Andriessen JA; Pereira P; Currie B; Goldstein EJ
    Curr Med Res Opin; 2013 Oct; 29(10):1341-7. PubMed ID: 23931498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Decade of Experience in Primary Prevention of Clostridium difficile Infection at a Community Hospital Using the Probiotic Combination Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+).
    Maziade PJ; Pereira P; Goldstein EJ
    Clin Infect Dis; 2015 May; 60 Suppl 2():S144-7. PubMed ID: 25922400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Bio-K+ for the prevention of
    Leal J; Shen Y; Faris P; Dalton B; Sabuda D; Ocampo W; Bresee L; Chow B; Fletcher JR; Henderson E; Kaufman J; Kim J; Raman M; Kraft S; Lamont NC; Larios O; Missaghi B; Holroyd-Leduc J; Louie T; Conly J
    Infect Control Hosp Epidemiol; 2024 Apr; 45(4):443-451. PubMed ID: 38073551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients.
    Gao XW; Mubasher M; Fang CY; Reifer C; Miller LE
    Am J Gastroenterol; 2010 Jul; 105(7):1636-41. PubMed ID: 20145608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation strategies for hospital-based probiotic administration in a stepped-wedge cluster randomized trial design for preventing hospital-acquired Clostridioides difficile infection.
    Bresee LC; Lamont N; Ocampo W; Holroyd-Leduc J; Sabuda D; Leal J; Dalton B; Kaufman J; Missaghi B; Kim J; Larios OE; Henderson E; Raman M; Fletcher JR; Faris P; Kraft S; Shen Y; Louie T; Conly JM
    BMC Health Serv Res; 2023 Dec; 23(1):1386. PubMed ID: 38082421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Acid-Dependent and Independent Effects of Lactobacillus acidophilus CL1285, Lacticaseibacillus casei LBC80R, and Lacticaseibacillus rhamnosus CLR2 on Clostridioides difficile R20291.
    Gunaratnam S; Diarra C; Paquette PD; Ship N; Millette M; Lacroix M
    Probiotics Antimicrob Proteins; 2021 Aug; 13(4):949-956. PubMed ID: 33492661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary prevention of Clostridium difficile infections with a specific probiotic combining Lactobacillus acidophilus, L. casei, and L. rhamnosus strains: assessing the evidence.
    McFarland LV; Ship N; Auclair J; Millette M
    J Hosp Infect; 2018 Aug; 99(4):443-452. PubMed ID: 29702133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multipronged intervention strategy to control an outbreak of Clostridium difficile infection (CDI) and its impact on the rates of CDI from 2002 to 2007.
    Weiss K; Boisvert A; Chagnon M; Duchesne C; Habash S; Lepage Y; Letourneau J; Raty J; Savoie M
    Infect Control Hosp Epidemiol; 2009 Feb; 30(2):156-62. PubMed ID: 19125681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timely Use of Probiotics in Hospitalized Adults Prevents Clostridium difficile Infection: A Systematic Review With Meta-Regression Analysis.
    Shen NT; Maw A; Tmanova LL; Pino A; Ancy K; Crawford CV; Simon MS; Evans AT
    Gastroenterology; 2017 Jun; 152(8):1889-1900.e9. PubMed ID: 28192108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of Global Strategies to Prevent Hospital-Onset Clostridium difficile Infection: Targeting Proton Pump Inhibitors and Probiotics.
    Lewis PO; Lundberg TS; Tharp JL; Runnels CW
    Ann Pharmacother; 2017 Oct; 51(10):848-854. PubMed ID: 28821215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+): Characterization, Manufacture, Mechanisms of Action, and Quality Control of a Specific Probiotic Combination for Primary Prevention of Clostridium difficile Infection.
    Auclair J; Frappier M; Millette M
    Clin Infect Dis; 2015 May; 60 Suppl 2():S135-43. PubMed ID: 25922399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A high-dose preparation of lactobacilli and bifidobacteria in the prevention of antibiotic-associated and Clostridium difficile diarrhoea in older people admitted to hospital: a multicentre, randomised, double-blind, placebo-controlled, parallel arm trial (PLACIDE).
    Allen SJ; Wareham K; Wang D; Bradley C; Sewell B; Hutchings H; Harris W; Dhar A; Brown H; Foden A; Gravenor MB; Mack D; Phillips CJ
    Health Technol Assess; 2013 Dec; 17(57):1-140. PubMed ID: 24309198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of a
    Alberda C; Marcushamer S; Hewer T; Journault N; Kutsogiannis D
    Nutrients; 2018 Apr; 10(5):. PubMed ID: 29701662
    [No Abstract]   [Full Text] [Related]  

  • 14. Effectiveness of Probiotic for Primary Prevention of Clostridium difficile Infection: A Single-Center Before-and-After Quality Improvement Intervention at a Tertiary-Care Medical Center.
    Trick WE; Sokalski SJ; Johnson S; Bunnell KL; Levato J; Ray MJ; Weinstein RA
    Infect Control Hosp Epidemiol; 2018 Jul; 39(7):765-770. PubMed ID: 29695310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotics and prevention of Clostridium difficile infection.
    Goldstein EJC; Johnson SJ; Maziade PJ; Evans CT; Sniffen JC; Millette M; McFarland LV
    Anaerobe; 2017 Jun; 45():114-119. PubMed ID: 27988389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Detecting and Isolating Clostridium difficile Carriers at Hospital Admission on the Incidence of C difficile Infections: A Quasi-Experimental Controlled Study.
    Longtin Y; Paquet-Bolduc B; Gilca R; Garenc C; Fortin E; Longtin J; Trottier S; Gervais P; Roussy JF; Lévesque S; Ben-David D; Cloutier I; Loo VG
    JAMA Intern Med; 2016 Jun; 176(6):796-804. PubMed ID: 27111806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospital-associated Clostridium difficile infection: is it necessary to track community-onset disease?
    Dubberke ER; McMullen KM; Mayfield JL; Reske KA; Georgantopoulos P; Warren DK; Fraser VJ
    Infect Control Hosp Epidemiol; 2009 Apr; 30(4):332-7. PubMed ID: 19239377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons learned from implementing Clostridium difficile-focused antibiotic stewardship interventions.
    Ostrowsky B; Ruiz R; Brown S; Chung P; Koppelman E; van Deusen Lukas C; Guo Y; Jalon H; Sumer Z; Araujo C; Sirtalan I; Brown C; Riska P; Currie B
    Infect Control Hosp Epidemiol; 2014 Oct; 35 Suppl 3():S86-95. PubMed ID: 25222903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptome analysis of the Clostridioides difficile response to a specific lactobacilli probiotic formulation: explanations for its mechanisms of action.
    Masset Z; Gunaratnam S; Millette M; McFarland LV; Lacroix M
    J Appl Microbiol; 2023 Mar; 134(3):. PubMed ID: 36898672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Institutional review of the implementation and use of a Clostridium difficile infection bundle and probiotics in adult trauma patients.
    Bommiasamy AK; Connelly C; Moren A; Dodgion C; Bestall K; Cline A; Martindale RG; Schreiber MA; Kiraly LN
    Am J Surg; 2018 May; 215(5):825-830. PubMed ID: 29490870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.